NanoHema Panel v2.0 targets 481 genes associated with hematologic malignancies, comprehensively covering a wide range of genetic alterations including base substitutions, insertions/deletions, amplifications, and gene fusions.
This panel consists of two components:
NanoHema Panel v2.0_DNA Tube: Covers 1.7 Mb of genomic regions, including full coding regions of 436 genes, partial intronic regions of 12 genes, and the IGH Switch regions.
NanoHema Panel v2.0_RNA Tube: Covers 146 genes, optimized for fusion gene detection.
By integrating multi-omics approaches, employing a highly targeted design, and enhancing clinical utility, NanoHema Panel v2.0 offers an efficient and cost-effective solution for precision diagnosis, treatment planning, and longitudinal management of hematologic malignancies